menu
    • menu

    Company profile for Regeneron Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Regeneron is a leading science and technology company delivering life-transforming medicines for serious diseases. Founded by physician-scientists nearly 30 years ago, our science-driven approach has resulted in four FDA-approved medicines and numerous product candidates in a range of diseases, including ophthalmology, rheumatoid arthritis, atopic dermatitis, asthma, pain, cancer and infectious diseases.In addition to our med...
    Regeneron is a leading science and technology company delivering life-transforming medicines for serious diseases. Founded by physician-scientists nearly 30 years ago, our science-driven approach has resulted in four FDA-approved medicines and numerous product candidates in a range of diseases, including ophthalmology, rheumatoid arthritis, atopic dermatitis, asthma, pain, cancer and infectious diseases.In addition to our medicines, our innovations include the VelociSuite® technologies, world-class manufacturing operations, one of the largest human genetics sequencing efforts in the world

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Regeneron PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    777 Old Saw Mill River Road Tarrytown, NY 10591
    Telephone
    Telephone
    +1 914-847-7000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.regeneron.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company-beta/13476?pathWildcard=13476
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/regeneron

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ASH: Regeneron eyes simpler regimens to grow bispecifics' reach
    ASH: Regeneron eyes simpler regimens to grow bispecifics' reach

    08 Dec 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/ash-regeneron-does-subtraction-bids-move-bispecifics-earlier-treatment-blood-cancers

    FIERCE PHARMA
    08 Dec 2025
    Share Share
    Lynozyfic Shows Strong Responses in NDMM Patients
    Lynozyfic Shows Strong Responses in NDMM Patients

    07 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/07/3201147/0/en/Lynozyfic-linvoseltamab-Monotherapy-in-Newly-Diagnosed-Multiple-Myeloma-NDMM-Shows-Impressive-Responses-Supporting-Rationale-as-a-Potential-Foundation-in-Frontline-Treatment.html

    GLOBENEWSWIRE
    07 Dec 2025
    Share Share
    Regeneron Inks $150 M Pact with Gene Writer Tessera
    Regeneron Inks $150 M Pact with Gene Writer Tessera

    01 Dec 2025

    // PRESS RELEASE

    https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-tessera-therapeutics-jointly-develop-tsra-196

    PRESS RELEASE
    01 Dec 2025
    Share Share
    EU Approves Dupixent As First Targeted Drug For Chronic Urticaria
    EU Approves Dupixent As First Targeted Drug For Chronic Urticaria

    26 Nov 2025

    // PRESS RELEASE

    https://www.sanofi.com/en/media-room/press-releases/2025/2025-11-25-06-00-00-3194015

    PRESS RELEASE
    26 Nov 2025
    Share Share
    EU Approves Libtayo as First CSCC Immunotherapy after Surgery
    EU Approves Libtayo as First CSCC Immunotherapy after Surgery

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3190794/0/en/Libtayo-cemiplimab-Approved-in-the-European-Union-as-First-and-Only-Immunotherapy-for-Adjuvant-Treatment-of-Cutaneous-Squamous-Cell-Carcinoma-CSCC-with-High-Risk-of-Recurrence-afte.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share
    FDA Approves Eylea HD 8 mg for RVO Macular Edema
    FDA Approves Eylea HD 8 mg for RVO Macular Edema

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3191435/0/en/EYLEA-HD-aflibercept-Injection-8-mg-Approved-by-FDA-for-the-Treatment-of-Macular-Edema-Following-Retinal-Vein-Occlusion-RVO-and-for-Monthly-Dosing-Across-Approved-Indications.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Regeneron Pharmaceuticals and get a quotation

    Regeneron Pharmaceuticals is a supplier offers 20 products (APIs, Excipients or Intermediates).

    Find a price of Cemiplimab bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Dupilumab bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Cells/Evinacumab Development Cell Bank bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Medium/Medium additives・RCDF7 Stock Feed Solution bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Medium / Medium Additives-CDM1B. C13 Seed Train Medium bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Medium / Medium Additives / RCDF2v3 stock fed solution bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Medium / Medium Additives / CDM1B. C13 Production Bioreactor Medium bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Medium / Medium Additives / RCDF2D stock fed solution bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Medium/medium additive ・RCDF1 stock feed solution bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Medium/medium additive ・RCDF4 stock feed solution bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Medium/Medium additives・RS5 30X stock feed solution bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Medium/medium additives/CDM1B. C13 Production Bioreactor Medium bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Medium / Medium Additives / RCDF2v2 stock fed solution bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Media/Media Additives CDM1B. C13 Cell Culture Medium bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Media/Media Additives CDM1B. C13 Production Bioreactor Medium bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Medium/Medium additives・RCDF7V2 Stock Feed Solution bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Medium / Medium Additives-CDM1B. C13 Production Bioreactor Medium bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Medium / Medium Additives / CDM1B. C13 Seed Train Medium bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of Medium/medium additive ・RCDF5 stock feed solution bulk with JDMF offered by Regeneron Pharmaceuticals

    Find a price of RILONACEPT bulk offered by Regeneron Pharmaceuticals

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search